Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
The World Health Organization has said that the Ebola Virus Disease (EVD) epidemic in West Africa is
The ICU is the last frontier of medical care, a symbol of both its promise and of its limits. Given the huge costs of operating an ICU, it is also an arena for intense debate about physician responsibility towards patients, in the face of growing competition for scarce medical resources. Rationalizing the use of ICUs and allocating beds to patients more likely to benefit from them has in fact been throwing up challenges for hospital management for over three decades. The biggest of these involves determining when life support should be ended for an ICU patient. In late 2013,
The ALARA principle (As Low As Reasonably Achievable) will remain the key method used to determine the proper exposure technique for a given examination. However, the technology and the methods used to achieve the lowest reasonably achievable dose will continue to evolve.
New, more efficient technology can have a significant impact on required dose levels. To confirm this, Agfa HealthCare conducted both a technical assessment and an image quality evaluation with radiologists. The goal of this evaluation was to determine by how much patient exposure (and dose) could be reduced while providing the same or similar image quality, comparing conventional BaFBr plate CR systems to CsBr needle plate CR systems and CsI needle scintillator DR detectors using Agfa HealthCare
Since the 1980s, endoscopy has rapidly grown to become the weapon of choice against a wide range of digestive diseases. The pace of growth has, however, led to concerns about quality.
Recent years have revealed there is much that can be improved in the effectiveness of endoscopy. As with other medical procedures, endoscopy
Ebola, a river in the northern Democratic Republic of Congo, has become a familiar name to all of us over the last few months with the ongoing outbreak of Ebola virus disease in West Africa.
by Prof. Jean-Louis Vincent
As of September 22, 2014, this outbreak has reportedly resulted in the deaths of more than 2800 people, although with the remoteness of many of the areas affected and limited laboratory and healthcare facilities, the World Health Organization and aid agencies on site believe the actual numbers of cases affected are likely to be much higher. Although reported mortality rates associated with the current outbreak are around 48%, rates are higher in more remote areas and previous outbreaks have been associated with rates as high as 90%.
Mode of transmission
The virus is transmitted to humans from infected animals, with the vector believed to be the fruit bat, and human-to-human transmission then occurs by direct contact with body fluids (urine, vomit, blood, saliva, semen) from infected patients. Incubation periods can be as long as 21 days and active virus can remain present in some body fluids, e.g., semen, for as long as 7 weeks after recovery from Ebola virus disease. Because of the mode of transmission, healthcare workers and close family members have been the prime victims in the current outbreak. The limited medical and infection control resources in West Africa have assisted the spread of the virus. The sheer extent of the current outbreak with spread to neighboring countries and the clear threat of transfer beyond the African continent via international travel have begun to mobilize the international community. But how does this disastrous event for western Africa really affect us as physicians in the developed world? What importance does it carry for the wider medical and intensive care community?
The implications for the developed world
First, those of us in the privileged position of working in organized and (relatively) well-resourced hospitals and intensive care units (ICUs) need to help and support our colleagues in West Africa, whether that be by offering time and travelling to assist locally, being prepared to adjust home rotas to free-up colleagues who wish to help overseas, provide financial or material support, accelerate research agendas for new vaccines and therapies, or on a more global, longer-term scale take part in initiatives to help prevent such an outbreak in the future by improving medical structure and facilities worldwide.
Second, we need to encourage strategies to contain the disease and prevent spread at the borders of affected countries and at home. As physicians, we have a vital role in educating those in the front-line, e.g. airline staff and border police, in the recognition of likely symptoms and essential initial infection control practices. Ebola virus disease is not spread by air, thus reducing the risks of disease transmission, but care is still required to avoid direct contact with any body fluids and the basics of infection control, such as hand-washing cannot be stressed enough. With the ease and speed of modern travel, everyone needs to be aware of the symptoms of Ebola virus disease and be alert to the possibility that anyone who has recently travelled to an infected area and presents with suggestive symptoms could be infected. Such cases should be managed appropriately with adequate infection control until tests results are available. Suspect cases have already presented to hospitals in various countries including Austria, Belgium, Germany and Canada
Medical imaging is confronted with heterogeneities in many areas, including education and training, research, and quality of equipment and practice, which calls for a pan-European approach.
by Prof. Guy FRIJA, Past-President of the European Society of Radiology (ESR)
In 2014, the European Commissions Expert Panel advising the European Commission on effective ways of investing in health recently adopted an opinion1 recommending specific actions to improve quality of care and patient safety.
The actions proposed in the expert panel
April 2024
The medical devices information portal connecting healthcare professionals to global vendors
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.
Accept settingsHide notification onlyCookie settingsWe may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.
Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.
We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.
We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.
.These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.
If you do not want us to track your visit to our site, you can disable this in your browser here:
.
We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page
Google Webfont Settings:
Google Maps Settings:
Google reCaptcha settings:
Vimeo and Youtube videos embedding:
.U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.
Privacy policy